Drug exposure and risk of microscopic colitis: A nationwide Danish case-control study with 5751 cases

Inflammatory Bowel Diseases

Volumn 20, Issue 10, 2014, Pages 1702-1707

  Bonderup, Ole K ^a   Fenger Grøn, Morten ^a,b   Wigh, Tatjana ^c   Pedersen, Lars ^b   Nielsen, Gunnar L ^d,e  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c RANDERS REGIONAL HOSPITAL   (Denmark)

^d Medical Department Hospital Himmerland   (Denmark)

^e AALBORG UNIVERSITY   (Denmark)

Author keywords

Collagenous colitis; Diarrhea; Drugs; Lymphocytic colitis; Microscopic colitis

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; COLLAGENOUS COLITIS; COLON BIOPSY; CONTROLLED STUDY; DANISH CITIZEN; DRUG EXPOSURE; ENDOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; MIDDLE AGED; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; CASE CONTROL STUDY; CHEMICALLY INDUCED; COLITIS, MICROSCOPIC; DENMARK; FOLLOW UP; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COLITIS, MICROSCOPIC; DENMARK; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 84922123963     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000143     Document Type: Article

References (23)

1. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology. 2011;140:1155-1165.
2. Jackson BK. Are collagenous colitis and lymphocytic colitis distinct syndromes? Dig Dis. 1995;13:301-311.
3. Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut. 2004;53:346-350.
4. Pardi DS, Loftus EV Jr, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut. 2007;56:504-508.
5. Wickbom A, Bohr J, Eriksson S, et al. Stable incidence of collagenous colitis and lymphocytic colitis in Örebro, Sweden, 1999-2008: a continuous epidemiologic study. Inflamm Bowel Dis. 2013;19:2387-2393.
6. Gentile NM, Khanna S, Loftus EV Jr, et al. The epidemiology of microscopic colitis in Olmsted County from 2002 to 2012: a population based study. Clin Gastroenterol Hepatol. 2014;12:838-848.
7. Jarnerot G, Tysk C, Bohr J, et al. Collagenous colitis and fecal stream diversion. Gastroenterology. 1995;109:449-455.
8. Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 2005;22:277-284.
9. Munch A, Soderholm JD, Wallon C, et al. Dynamics of mucosal permeability and inflammation in collagenous colitis before, during, and after loop ileostomy. Gut. 2005;54:1126-1128.
10. Fernandez-Banares F, Esteve M, Espinos JC, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol. 2007;102:324-330.
11. Pascua MF, Kedia P, Weiner MG, et al. Microscopic colitis and medication use. Clin Med Insights Gastroenterol. 2010;2010:11-19.
12. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39:22-25.
13. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39:30-33.
14. Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39:72-74.
15. Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39:38-41.
16. Capella D. Descriptive tools and analysis. WHO Reg Publ Eur Ser. 1993;45:55-78.
17. Andersen JS, Olivarius NF, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011;39:34-37.
18. Szklo M, Nieto MF. Epidemiology. Beyond the Basics. Gaitersberg, MD: Aspen Publishers Inc., 2000.
19. Limsui D, Pardi DS, Smyrk TC, et al. Observer variability in the histologic diagnosis of microscopic colitis. Inflamm Bowel Dis. 2009;15:35-38.
20. Shapiro S. Case-control surveillance. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. Chichester, NH: John Wiley & Sons, 1994:301-322.
21. MEDSTAT. DK [online database]. Available at www.medstat.dk. Last modified June 7, 2014.
22. Grimes DA, Schulz KF. False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet Gynecol. 2012;120:920-927.
23. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15-19.